One year follow-up of children and adolescents with chronic Immune Thrombocytopenic Purpura (ITP) treated with rituximab Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Purpura, Thrombocytopenic, Idiopathic

abstract

  • Rituximab resulted in sustained efficacy with platelet counts of 50,000/mm(3) or higher in 11 of 36 patients (31%).

publication date

  • February 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/pbc.21757

PubMed ID

  • 18937333

Additional Document Info

start page

  • 259

end page

  • 62

volume

  • 52

number

  • 2